Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely
Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...
FiercePharma12h
Government watchdog recommends tweaks to FDA accelerated approval program
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research ...
GlobalData on MSN14h
Santhera launches DMD therapy in the UK following NICE nod
Santhera Pharmaceuticals has started launch preparations for its DMD drug Agamree (vamorolone) in the UK, after a ...
Bank of America Securities Remains a Hold on Kymera Therapeutics (KYMR)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Hold rating on Kymera Therapeutics (KYMR – Research ...
U.S. budget deficit grows to over $700 billion
Swings in the bond market recently sent the yield on the 10-year Treasury above 4.80% and its highest level since 2023. The ...
Regenxbio Secures A Partnership With Nippon Shinyaku For RGX-111 & 121
REGENXBIO's partnership with Nippon Shinyaku provides $110M upfront, ensuring a cash runway for gene therapy programs in MPS ...
Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight
The rising incidence of cancer is boosting the demand for advanced diagnostic tools, such as exosome-based diagnostics, which provide non-invasive and accurate detection methods. In addition to ...
Beacon encouraging mask use at hospitals
On Wednesday, Beacon Health System hospital began strongly encouraging visitors to wear masks when directly interacting with hospitalized patients due to an increase of respiratory illness in the ...